Our analysis identified three candidate genes with increased expression in cancer tissues, with elevated levels associated with poor survival across multiple cancer types: the 5-methylcytosine methyltransferases NSUN2 and DNMT3B and CBP20, an N<sup>7</sup>-methylguanosine binding protein. This evidence concerns the gene NCBP2 and cancer.